Cargando…

d‐Pinitol promotes tau dephosphorylation through a cyclin‐dependent kinase 5 regulation mechanism: A new potential approach for tauopathies?

BACKGROUND AND PURPOSE: Recent evidence links brain insulin resistance with neurodegenerative diseases, where hyperphosphorylated tau protein contributes to neuronal cell death. In the present study, we aimed to evaluate if d‐pinitol inositol, which acts as an insulin sensitizer, affects the phospho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Medina‐Vera, Dina, Navarro, Juan Antonio, Rivera, Patricia, Rosell‐Valle, Cristina, Gutiérrez‐Adán, Alfonso, Sanjuan, Carlos, López‐Gambero, Antonio Jesús, Tovar, Rubén, Suárez, Juan, Pavón, Francisco Javier, Baixeras, Elena, Decara, Juan, Rodríguez de Fonseca, Fernando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544772/ https://www.ncbi.nlm.nih.gov/pubmed/35760415 http://dx.doi.org/10.1111/bph.15907

Ejemplares similares

Novel insights into D-Pinitol based therapies: a link between tau hyperphosphorylation and insulin resistance
por: Medina-Vera, Dina, et al.
Publicado: (2023)

Activation of PI3K/Akt Signaling Pathway in Rat Hypothalamus Induced by an Acute Oral Administration of D-Pinitol
por: Medina-Vera, Dina, et al.
Publicado: (2021)

Pharmacokinetics and Endocrine Effects of an Oral Dose of D-Pinitol in Human Fasting Healthy Volunteers
por: Navarro, Juan A., et al.
Publicado: (2022)

Endocrine and Metabolic Impact of Oral Ingestion of a Carob-Pod-Derived Natural-Syrup-Containing D-Pinitol: Potential Use as a Novel Sweetener in Diabetes
por: Navarro, Juan A., et al.
Publicado: (2022)

D-Pinitol from Ceratonia siliqua Is an Orally Active Natural Inositol That Reduces Pancreas Insulin Secretion and Increases Circulating Ghrelin Levels in Wistar Rats
por: Navarro, Juan A., et al.
Publicado: (2020)

Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases
por: Decara, Juan, et al.
Publicado: (2020)

A Negative Energy Balance Is Associated with Metabolic Dysfunctions in the Hypothalamus of a Humanized Preclinical Model of Alzheimer’s Disease, the 5XFAD Mouse
por: López-Gambero, Antonio J., et al.
Publicado: (2021)

The adiponectin promoter activator NP-1 induces high levels of circulating TNFα and weight loss in obese (fa/fa) Zucker rats
por: Decara, Juan, et al.
Publicado: (2018)

A novel dephosphorylation targeting chimera selectively promoting tau removal in tauopathies
por: Zheng, Jie, et al.
Publicado: (2021)

Increasing Tau 4R Tau Levels Exacerbates Hippocampal Tau Hyperphosphorylation in the hTau Model of Tauopathy but Also Tau Dephosphorylation Following Acute Systemic Inflammation
por: Barron, Matthew R., et al.
Publicado: (2020)

The Role of Microglia in the Spread of Tau: Relevance for Tauopathies
por: Perea, Juan R., et al.
Publicado: (2018)

Imbalance of Endocannabinoid/Lysophosphatidylinositol Receptors Marks the Severity of Alzheimer’s Disease in a Preclinical Model: A Therapeutic Opportunity
por: Medina-Vera, Dina, et al.
Publicado: (2020)

Chronic IL-6 Administration Desensitizes IL-6 Response in Liver, Causes Hyperleptinemia and Aggravates Steatosis in Diet-Induced-Obese Mice
por: Gavito, Ana Luisa, et al.
Publicado: (2016)

Involvement of Oligodendrocytes in Tau Seeding and Spreading in Tauopathies
por: Ferrer, Isidro, et al.
Publicado: (2019)

Transcellular Spreading of Tau in Tauopathies
por: Demaegd, Koen, et al.
Publicado: (2018)

Are Tau Aggregates Toxic or Protective in Tauopathies?
por: Cowan, Catherine M., et al.
Publicado: (2013)

NMR Studies of Tau Protein in Tauopathies
por: Kitoka, Kristine, et al.
Publicado: (2021)

Phosphorylation and Dephosphorylation of Tau Protein by the Catalytic Subunit of PKA, as Probed by Electrophoretic Mobility Retard
por: Benítez, María J., et al.
Publicado: (2021)

Hippocampal Synaptic Alterations Associated with Tau Pathology in Primary Age-Related Tauopathy
por: Morris, Meaghan, et al.
Publicado: (2023)

Tau exon 10 alternative splicing and tauopathies
por: Liu, Fei, et al.
Publicado: (2008)

Glial Tau Pathology in Tauopathies: Functional Consequences
por: Kahlson, Martha A., et al.
Publicado: (2016)

Tau Spreading Mechanisms; Implications for Dysfunctional Tauopathies
por: Fuster-Matanzo, Almudena, et al.
Publicado: (2018)

Targeting tauopathy with engineered tau-degrading intrabodies
por: Gallardo, Gilbert, et al.
Publicado: (2019)

Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies
por: Rawat, Priyanka, et al.
Publicado: (2022)

Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice
por: Vida, Margarita, et al.
Publicado: (2015)

Acetaminophen-Induced Liver Injury Alters the Acyl Ethanolamine-Based Anti-Inflammatory Signaling System in Liver
por: Rivera, Patricia, et al.
Publicado: (2017)

Cerebral Microvascular Accumulation of Tau Oligomers in Alzheimer’s Disease and Related Tauopathies
por: Castillo-Carranza, Diana L, et al.
Publicado: (2017)

Calcineurin regulates cyclin D1 stability through dephosphorylation at T286
por: Goshima, Takahiro, et al.
Publicado: (2019)

Phosphorylation and Dephosphorylation of Tau Protein During Synthetic Torpor
por: Luppi, Marco, et al.
Publicado: (2019)

The Biomedical Uses of Inositols: A Nutraceutical Approach to Metabolic Dysfunction in Aging and Neurodegenerative Diseases
por: López-Gambero, Antonio J., et al.
Publicado: (2020)

Palmitoleoylethanolamide Is an Efficient Anti-Obesity Endogenous Compound: Comparison with Oleylethanolamide in Diet-Induced Obesity
por: Tovar, Rubén, et al.
Publicado: (2021)

Treatment with a novel oleic-acid–dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker rats
por: Decara, Juan M., et al.
Publicado: (2015)

D-Pinitol—Active Natural Product from Carob with Notable Insulin Regulation
por: Azab, Abdullatif
Publicado: (2022)

PET Imaging of Tau Pathology in Alzheimer’s Disease and Tauopathies
por: James, Olga G., et al.
Publicado: (2015)

Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?
por: Laurent, Cyril, et al.
Publicado: (2018)

VPS35 regulates tau phosphorylation and neuropathology in tauopathy
por: Vagnozzi, Alana N., et al.
Publicado: (2021)

Colocalization of BRCA1 with Tau Aggregates in Human Tauopathies
por: Kurihara, Masanori, et al.
Publicado: (2019)

TBK1 interacts with tau and enhances neurodegeneration in tauopathy
por: Abreha, Measho H., et al.
Publicado: (2021)

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies
por: Trojanowski, John Q
Publicado: (2013)

Phospho-Tau Bar Code: Analysis of Phosphoisotypes of Tau and Its Application to Tauopathy
por: Kimura, Taeko, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_v8gm8v0ef2u054erhcvta7sjij